Celsion Announces Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer Reaches Target Number of Events for Unblinding

[at noodls] – Company Begins Data Collection, Expects to Report Top Line Data in January 2013; Reiterates Strong Balance Sheet Position LAWRENCEVILLE, NJ — (Marketwire) — 11/09/12 — Celsion Corporation (NASDAQ: CLSN), … more

View todays social media effects on CLSN

View the latest stocks trending across Twitter. Click to view dashboard